Pfizer CEO Reveals High-Stakes Talks with Trump Team: Tariffs & Most Favored Nations Pricing Under Fire
Big Pharma meets bare-knuckle politics—Pfizer's CEO just pulled back the curtain on explosive negotiations with the Trump administration.
Tariffs, pricing models, and the infamous 'Most Favored Nation' clause are all on the table as DC and Big Pharma clash over who controls the profit levers.
Meanwhile, Wall Street analysts whisper: 'Just another day of healthcare stocks being held hostage by political theater.'